Huntington National Bank’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.54K | Sell |
1
-243
| -100% | -$617K | ﹤0.01% | 2154 |
|
|
2025
Q1 | $32.2K | Sell |
244
-188
| -44% | -$24.8K | ﹤0.01% | 1361 |
|
|
2024
Q4 | $36.1K | Sell |
432
-54
| -11% | -$4.51K | ﹤0.01% | 1342 |
|
|
2024
Q3 | $35.6K | Buy |
486
+57
| +13% | +$4.17K | ﹤0.01% | 1310 |
|
|
2024
Q2 | $29.4K | Sell |
429
-79
| -16% | -$5.41K | ﹤0.01% | 1343 |
|
|
2024
Q1 | $35.2K | Buy |
508
+22
| +5% | +$1.52K | ﹤0.01% | 1257 |
|
|
2023
Q4 | $34.8K | Sell |
486
-89
| -15% | -$6.37K | ﹤0.01% | 1222 |
|
|
2023
Q3 | $30K | Sell |
575
-89
| -13% | -$4.64K | ﹤0.01% | 1210 |
|
|
2023
Q2 | $42K | Buy |
664
+217
| +49% | +$13.7K | ﹤0.01% | 1108 |
|
|
2023
Q1 | $24.2K | Buy |
447
+97
| +28% | +$5.25K | ﹤0.01% | 1249 |
|
|
2022
Q4 | $18.5K | Sell |
350
-34
| -9% | -$1.8K | ﹤0.01% | 1309 |
|
|
2022
Q3 | $18K | Buy |
384
+23
| +6% | +$1.08K | ﹤0.01% | 1339 |
|
|
2022
Q2 | $21K | Buy |
361
+315
| +685% | +$18.3K | ﹤0.01% | 1321 |
|
|
2022
Q1 | $3K | Buy |
+46
| New | +$3K | ﹤0.01% | 1867 |
|